Article
Spiroketal formation and modification in avermectin biosynthesis involves a dual activity of AveC.
Journal of the American Chemical Society - 30 Jan 2013
Sun Peng, Zhao Qunfei, Yu Futao, Zhang Hua, Wu Zhuhua, Wang Yinyan, Wang Yan, Zhang Qinglin, Liu Wen
Abstract excerpt
Avermectins (AVEs), which are widely used for the treatment of agricultural parasitic diseases, belong to a family of 6,6-spiroketal moiety-containing, macrolide natural products. AVE biosynthesis is known to employ a type I polyketide synthase (PKS) system to assemble the molecular skeleton for further functionalization. It remains unknown how and when spiroketal formation proceeds, particularly regarding the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
